Table 3.

Treatments used for patients with COVID-19 according to the severity of disease

CharacteristicsTotal (n=131)Mild/Moderate (n=101)Severe/Critical (n=30)P Valuea
Present hemodialysis modality, n (%)
 Hemodialysis77 (58.8)64 (63.4)13 (43.3)0.05
 CRRT36 (27.5)24 (23.8)12 (40.0)0.08
 Hemodiafiltration5 (3.8)2 (2.0)3 (10.0)0.08a
Days from COVID-19 diagnosis to first dialysis, median (IQR)3.5 (2.0–6.0)4.0 (2.0–6.0)2.6 (2.0–9.0)0.64b
Drugs, n (%)
 Antivirals (n=115)92 (80.0)66 (75.9)26 (92.9)0.05
 Antibiotics (n=109)92 (84.4)65 (80.3)27 (96.4)0.07a
 Glucocorticoids (n=110)19 (17.3)9 (10.7)10 (38.5)0.002a
 Chinese medicine (n=90)66 (73.3)52 (80.0)14 (56.0)0.02
Mechanical ventilation, n (%)
 Noninvasive (n=110)23 (20.9)16 (19.3)7 (25.9)0.46
 Invasive (n=109)2 (1.8)0 (0.0)2 (7.4)0.06a
  • P values were calculated by the t test or Wilcoxon test for continuous variables, and the chi-squared test for categorical variables, otherwise Fisher’s exact test was used when the data were limited. CRRT, continuous RRT.

  • a P values from Fisher’s exact test.

  • b P values from the Wilcoxon test.